NCT05853458 Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors Status TERMINATED Phase PHASE4
NCT05853445 A Prospective, Non-interventional Study of JAKAVI® (Ruxolitinib) Treatment in Patients With Polycythemia Vera Status COMPLETED Phase N/A
NCT05853432 A Descriptive Study of Baseline Characteristics, Clinical Outcomes, and Treatment Patterns of HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Alpelisib Plus Fulvestrant Who Have Received Fulvestrant in Any Prior Line of Therapy Status COMPLETED Phase N/A
NCT05852938 A Study of Zigakibart in Adults With IgA Nephropathy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05849298 A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05848219 Healthcare Resource Utilization and Costs in Metastatic Melanoma Patients Initiated Dabrafenib + Trametinib and Encorafenib + Binimetinib Status TERMINATED Phase N/A
NCT05848206 Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S. Status COMPLETED Phase N/A
NCT05842954 Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria Status COMPLETED Phase PHASE3
NCT05838768 Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05834738 Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy Status COMPLETED Phase PHASE2
NCT05834075 A Retrospective Study to Evaluate the Early Real-world Evidence of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) in India Status COMPLETED Phase N/A
NCT05833022 Patient Characteristics and Treatment Patterns From Early Crizanlizumab Use in Real-world Setting: Preliminary Analysis From Select Sickle Cell Centers Status COMPLETED Phase N/A
NCT05827081 Phase IIIb Study of Ribociclib + ET in Early Breast Cancer Status RECRUITING Phase PHASE3
NCT05826028 Mayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGo Status COMPLETED Phase N/A
NCT05816720 Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®) Status COMPLETED Phase N/A
NCT05815212 Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial Intensive Treatment in the Real World Clinical Setting in Korea (Rising K) Status COMPLETED Phase N/A
NCT05809986 Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study Status RECRUITING Phase N/A